Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Case of Classical Hodgkin Lymphoma with Total Lymph Node Infarction.
Okuni M, Yakushijin K, Sakai Y, Suto H, Ichikawa H, Sakai R, Kakiuchi S, Kurata K, Mizutani Y, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Minami H. Okuni M, et al. Among authors: suto h. J Clin Exp Hematop. 2018 Mar 16;58(1):24-26. doi: 10.3960/jslrt.17026. Epub 2018 Feb 8. J Clin Exp Hematop. 2018. PMID: 29415974 Free PMC article.
Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.
Goto H, Kiyota N, Otsuki N, Imamura Y, Chayahara N, Suto H, Nagatani Y, Toyoda M, Mukohara T, Nibu KI, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H. Goto H, et al. Among authors: suto h. Auris Nasus Larynx. 2018 Dec;45(6):1249-1252. doi: 10.1016/j.anl.2018.05.003. Epub 2018 May 18. Auris Nasus Larynx. 2018. PMID: 29779695
Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
Okuni M, Yakushijin K, Uehara K, Ichikawa H, Suto H, Hashimoto A, Tanaka Y, Shinzato I, Sakai R, Mizutani Y, Nagao S, Kurata K, Kakiuchi S, Miyata Y, Inui Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Minami H. Okuni M, et al. Among authors: suto h. Intern Med. 2019 Mar 1;58(5):707-712. doi: 10.2169/internalmedicine.1266-18. Epub 2018 Nov 19. Intern Med. 2019. PMID: 30449784 Free PMC article.
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Suzuki C, Kiyota N, Imamura Y, Goto H, Suto H, Chayahara N, Toyoda M, Ito Y, Miya A, Miyauchi A, Teshima M, Otsuki N, Nibu KI, Minami H. Suzuki C, et al. Among authors: suto h. Front Oncol. 2021 Jul 8;11:638123. doi: 10.3389/fonc.2021.638123. eCollection 2021. Front Oncol. 2021. PMID: 34307122 Free PMC article.
Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
Nagatani Y, Funakoshi Y, Suto H, Imamura Y, Toyoda M, Kiyota N, Yamashita K, Minami H. Nagatani Y, et al. Among authors: suto h. J Cancer Res Ther. 2021 Jul-Sep;17(4):1093-1100. doi: 10.4103/jcrt.JCRT_1222_20. J Cancer Res Ther. 2021. PMID: 34528569 Free article.
244 results